Trademark: 90647320
Word
BEIGENE
Status Date
Tuesday, September 27, 2022
Registration Number
6860858
Registration Date
Tuesday, September 27, 2022
Filing Date
Thursday, April 15, 2021
Published for Opposition
Tuesday, October 19, 2021
40 Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
5 Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
44 Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
42 Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
The mark consists of a shaded square in red with a stylized red square and a star cutout in the center of the stylized square to the left of the black wording "BeiGene" with a red arrow as part of the letter "G.
The color(s) red and black is/are claimed as a feature of the mark.
Mar 24, 2023
Teas Change Of Correspondence Received
Mar 24, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 24, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 8, 2022
Teas Change Of Correspondence Received
Dec 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 8, 2022
Teas Change Of Owner Address Received
Sep 27, 2022
Notice Of Registration Confirmation Emailed
Sep 27, 2022
Registered-Principal Register
Aug 23, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 22, 2022
Allowed Principal Register - Sou Accepted
Aug 19, 2022
Teas/Email Correspondence Entered
Aug 18, 2022
Correspondence Received In Law Office
Aug 18, 2022
Teas Request For Reconsideration Received
Aug 11, 2022
Notification Of Final Refusal Emailed
Aug 11, 2022
Final Refusal E-Mailed
Aug 11, 2022
Su - Final Refusal - Written
Jul 12, 2022
Teas/Email Correspondence Entered
Jul 12, 2022
Correspondence Received In Law Office
Jul 11, 2022
Teas Response To Office Action Received
Jul 7, 2022
Notification Of Non-Final Action E-Mailed
Jul 7, 2022
Non-Final Action E-Mailed
Jul 7, 2022
Su - Non-Final Action - Written
Jun 1, 2022
Data Modification Completed
Jun 1, 2022
Assigned To Lie
May 26, 2022
Statement Of Use Processing Complete
May 12, 2022
Use Amendment Filed
May 26, 2022
Case Assigned To Intent To Use Paralegal
May 12, 2022
Teas Statement Of Use Received
Dec 14, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 19, 2021
Published For Opposition
Sep 29, 2021
Notification Of Notice Of Publication E-Mailed
Sep 13, 2021
Approved For Pub - Principal Register
Sep 8, 2021
Assigned To Examiner
Jul 23, 2021
Notice Of Design Search Code E-Mailed
Jul 22, 2021
New Application Office Supplied Data Entered
Apr 19, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
